TLSI logo

TriSalus Life Sciences, Inc. Common Stock


TLSI: TriSalus Life Sciences Inc is an oncology company integrating standard-of-care treatments and its investigational immunotherapeutic, SD-101, with disruptive Pressure Enabled Drug Delivery infusion systems to transform the treatment paradigm for patients battling liver and pancreatic tumors. TriSalus is a commercial-stage medical device and Phase I clinical-stage pharmaceutical company.


Show TLSI Financials

Consumer Interest
SEC Filings

Recent trades of TLSI by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard

Recently reported changes by institutional investors

Quiver Logo

No Whale Activity for this ticker

Institutional Holdings Dashboard

Quarterly net insider trading by TLSI's directors and management

Quiver Logo

No recent Insider Trading for this ticker

Insider Trading Dashboard

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

  • Patent Title: System and method for selective pressure-controlled therapeutic delivery Aug. 02, 2022
  • Patent Title: Implantable dual pathway therapeutic agent delivery port May. 24, 2022
  • Patent Title: Immunostimulatory sequence oligonucleotides and methods of using the same Apr. 26, 2022
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard

Number of mentions of TLSI in WallStreetBets Daily Discussion


Recent insights relating to TLSI

CNBC Recommendations

Recent picks made for TLSI stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in TLSI

Corporate Flights

Flights by private jets registered to TLSI